文献速递慢性肾脏病遗传性与小管间质肾病

通过检测单基因突变实现慢性肾脏病的个体化医疗

Personalized medicine in chronic kidney disease by detection of monogenic mutations.
PubMed 文献 · Nephrol Dial Transplant · 2020-01-01

本文综述了已知约450个单基因突变可导致慢性肾脏病(CKD),可解释约30%的儿童队列和约5-30%的成人队列病例。文章概述了当前已知的单基因CKD病因,并描述了下一代测序如何促进疑似遗传性肾病的快速分子遗传学诊断,强调基因检测对个体化治疗策略的指导意义。

要点

  • 约450个单基因突变已知可导致CKD,解释约30%儿童和5-30%成人CKD病例。
  • 下一代测序可促进疑似遗传性肾病的快速分子遗传学诊断。
  • 检出单基因病因(如HNF1B突变)有助于分子诊断、家系筛查和个体化治疗。

核心结论

  • 检测单基因突变可实现对CKD患者的分子遗传学诊断,并为个体化治疗策略开辟途径。

研究设计与样本

  • 本文为综述,概述了目前已知的人类CKD单基因病因,并描述了下一代测序在疑似遗传性肾病诊断中的应用。

主要发现

  • 约450个单基因(单基因病)基因若突变已知可导致CKD,解释约30%的儿童队列病例和约5-30%的成人队列病例。
  • 全外显子或全基因组测序可能揭示数百个额外的单基因肾病基因。
  • 成人群体中仍存在显著挑战,包括广泛表型异质性、表现度变异、不完全外显或年龄相关外显。
  • 检出HNF1B致病突变不仅可正式诊断CKD,还有助于筛查其他肾外表现,如青年发病的成年型糖尿病、亚临床肝功能异常、新生儿胆汁淤积和胰腺发育不全。

临床怎么用

  • 对疑似遗传性肾病的个体,应考虑下一代测序以快速获得分子遗传学诊断。
  • 检出单基因病因可指导患者和家族的分子诊断,并开启个体化治疗策略。
  • HNF1B突变检出后应筛查肾外表现,如青年发病的成年型糖尿病、肝功能异常、新生儿胆汁淤积和胰腺发育不全。

局限性

  • 成人群体中广泛表型异质性、表现度变异、不完全外显或年龄相关外显给基因发现带来显著挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A large fraction of early-onset chronic kidney disease (CKD) is known to be monogenic in origin. To date, ∼450 monogenic (synonymous with single-gene disorders) genes, if mutated, are known to cause CKD, explaining ∼30% of cases in pediatric cohorts and ∼5-30% in adult cohorts. However, there are likely hundreds of additional monogenic nephropathy genes that may be revealed by whole-exome or -genome sequencing. Although the discovery of novel CKD-causing genes has accelerated, significant challenges in adult populations remain due to broad phenotypic heterogeneity together with variable expressivity, incomplete penetrance or age-related penetrance of these genes. Here we give an overview of the currently known monogenic causes for human CKD. We also describe how next-generation sequencing facilitates rapid molecular genetic diagnostics in individuals with suspected genetic kidney disease. In an era of precision medicine, understanding the utility of genetic testing in individuals with a suspected inherited nephropathy has important diagnostic and prognostic implications. Detection of monogenic causes of CKD permits molecular genetic diagnosis for patients and families and opens avenues for personalized treatment strategies for CKD. As an example, detection of a pathogenic mutation in the gene HNF1B not only allows for the formal diagnosis of CKD, but can also facilitate screening for additional extrarenal manifestations of disease, such as maturity-onset diabetes of youth, subclinical abnormal liver function tests, neonatal cholestasis and pancreatic hypoplasia. It also provides the driving force towards a better understanding of disease pathogenesis, potentially facilitating targeted new therapies for individuals with CKD.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Connaughton DM, Hildebrandt F. Personalized medicine in chronic kidney disease by detection of monogenic mutations. Nephrol Dial Transplant. 2020. PMID: 30809662. doi:10.1093/ndt/gfz028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。